119 related articles for article (PubMed ID: 10071985)
1. Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin.
Dvorakova K; Dorr RT; Valcic S; Timmermann B; Alberts DS
Cancer Chemother Pharmacol; 1999; 43(4):331-5. PubMed ID: 10071985
[TBL] [Abstract][Full Text] [Related]
2. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
[TBL] [Abstract][Full Text] [Related]
3. Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice.
Lambert JD; Kim DH; Zheng R; Yang CS
J Pharm Pharmacol; 2006 May; 58(5):599-604. PubMed ID: 16640828
[TBL] [Abstract][Full Text] [Related]
4. (-)-Epigallocatechin-3-gallate in Camellia sinensis leaves from Himalayan region of Sikkim: inhibitory effects against biochemical events and tumor initiation in Sencar mouse skin.
Katiyar SK; Agarwal R; Wang ZY; Bhatia AK; Mukhtar H
Nutr Cancer; 1992; 18(1):73-83. PubMed ID: 1408948
[TBL] [Abstract][Full Text] [Related]
5. Photodegradation of (-)-epigallocatechin-3-gallate in topical cream formulations and its photostabilization.
Bianchi A; Marchetti N; Scalia S
J Pharm Biomed Anal; 2011 Dec; 56(4):692-7. PubMed ID: 21807473
[TBL] [Abstract][Full Text] [Related]
6. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
Liao B; Ying H; Yu C; Fan Z; Zhang W; Shi J; Ying H; Ravichandran N; Xu Y; Yin J; Jiang Y; Du Q
Int J Pharm; 2016 Oct; 512(1):22-31. PubMed ID: 27544847
[TBL] [Abstract][Full Text] [Related]
7. Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green tea.
Gensler HL; Timmermann BN; Valcic S; Wächter GA; Dorr R; Dvorakova K; Alberts DS
Nutr Cancer; 1996; 26(3):325-35. PubMed ID: 8910914
[TBL] [Abstract][Full Text] [Related]
8. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
9. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin.
Katiyar SK; Matsui MS; Elmets CA; Mukhtar H
Photochem Photobiol; 1999 Feb; 69(2):148-53. PubMed ID: 10048310
[TBL] [Abstract][Full Text] [Related]
10. Skin penetration of epigallocatechin-3-gallate and quercetin from green tea and Ginkgo biloba extracts vehiculated in cosmetic formulations.
dal Belo SE; Gaspar LR; Maia Campos PM; Marty JP
Skin Pharmacol Physiol; 2009; 22(6):299-304. PubMed ID: 19786823
[TBL] [Abstract][Full Text] [Related]
11. Dermal toxicity of topical (-)epigallocatechin-3-gallate in BALB/c and SKH1 mice.
Stratton SP; Bangert JL; Alberts DS; Dorr RT
Cancer Lett; 2000 Sep; 158(1):47-52. PubMed ID: 10940508
[TBL] [Abstract][Full Text] [Related]
12. Effects of polyphenols on skin damage due to ultraviolet A rays: an experimental study on rats.
Sevin A; Oztaş P; Senen D; Han U; Karaman C; Tarimci N; Kartal M; Erdoğan B
J Eur Acad Dermatol Venereol; 2007 May; 21(5):650-6. PubMed ID: 17447979
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of the tea polyphenol epigallocatechin-3-gallate encapsulated in targeted vesicles after intravenous administration.
Lemarié F; Chang CW; Blatchford DR; Amor R; Norris G; Tetley L; McConnell G; Dufès C
Nanomedicine (Lond); 2013 Feb; 8(2):181-92. PubMed ID: 22891867
[TBL] [Abstract][Full Text] [Related]
14. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells.
Hong J; Lu H; Meng X; Ryu JH; Hara Y; Yang CS
Cancer Res; 2002 Dec; 62(24):7241-6. PubMed ID: 12499265
[TBL] [Abstract][Full Text] [Related]
15. Effect of nutrient mixture and black grapes on the pharmacokinetics of orally administered (-)epigallocatechin-3-gallate from green tea extract: a human study.
Gawande S; Kale A; Kotwal S
Phytother Res; 2008 Jun; 22(6):802-8. PubMed ID: 18446840
[TBL] [Abstract][Full Text] [Related]
16. Absorption, tissue distribution and elimination of 4-[(3)h]-epigallocatechin gallate in beagle dogs.
Swezey RR; Aldridge DE; LeValley SE; Crowell JA; Hara Y; Green CE
Int J Toxicol; 2003; 22(3):187-93. PubMed ID: 12851151
[TBL] [Abstract][Full Text] [Related]
17. In vivo human skin penetration of (-)-epigallocatechin-3-gallate from topical formulations.
Scalia S; Trotta V; Bianchi A
Acta Pharm; 2014 Jun; 64(2):257-65. PubMed ID: 24914725
[TBL] [Abstract][Full Text] [Related]
18. Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas.
Fang JY; Lee WR; Shen SC; Huang YL
J Dermatol Sci; 2006 May; 42(2):101-9. PubMed ID: 16423506
[TBL] [Abstract][Full Text] [Related]
19. Prevention of UVB-induced immunosuppression in mice by the green tea polyphenol (-)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production.
Katiyar SK; Challa A; McCormick TS; Cooper KD; Mukhtar H
Carcinogenesis; 1999 Nov; 20(11):2117-24. PubMed ID: 10545414
[TBL] [Abstract][Full Text] [Related]
20. Transdermal delivery of tea catechins by electrically assisted methods.
Fang JY; Hung CF; Hwang TL; Wong WW
Skin Pharmacol Physiol; 2006; 19(1):28-37. PubMed ID: 16247247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
